CaseVuCategory Archives: Press Releases
Precipio’s Operational Efficiency Measures Continue To Reduce Cash Burn And Move The Company Towards Breakeven
Revenue growth and customer pipeline advance the Company towards breakeven NEW HAVEN, CT, Globenewswire – [...]
Aug
Precipio Unaudited Q2-2023 Revenues Show combined increase of 25% over Q1-2023
Revenue growth and customer pipeline advance the Company towards breakeven NEW HAVEN, CT, Globenewswire – [...]
Aug
Precipio Enters into Collaboration with Prestigious New York-based Institution to Develop Revolutionary Brain Tumor Panel using HemeScreen® Technology
New panel will enable rapid, precise genetic profiling of patients with deadly disease NEW HAVEN, [...]
Jun
Precipio, Inc. Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement
NEW HAVEN, CT, (June 8th, 2023) – Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today announced it [...]
Jun
Projected cash burn reduced by $1.5 million annually from Three Operational Efficiency Projects
Independent of revenue growth, these Projects expected to decrease cash burn by 25% in Q3 [...]
Jun
Precipio Shares Growth Catalysts For HemeScreen
Q1 Results and catalysts show promising growth trajectory NEW HAVEN, CT, (May 17th, 2023) – Specialty [...]
May
Precipio Announces Q1-2023 Shareholder Update Call
Conference Call to be held on May 17, 2023 at 5:00 PM EST NEW HAVEN, [...]
May
Precipio Adds Substantial Pathology Customer to its Diagnostic Services Division
Customer’s pathology services annual revenues expected to exceed $1.5M NEW HAVEN, CT, Globenewswire – (May [...]
May
Precipio Signs Another HemeScreen™ Customer
Customer’s revenues expected at $750K at full capacity NEW HAVEN, CT, Globenewswire – (May 4th, [...]
May
Precipio Granted 180-day Extension From NASDAQ To Regain Compliance
Extension will enable the Company to execute on its growth and advance toward breakeven NEW [...]
Apr